Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Acute Toxicity: other routes

Currently viewing:

Administrative data

Endpoint:
acute toxicity: other routes
Type of information:
experimental study
Adequacy of study:
supporting study
Study period:
No data
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: Meets generally accepted scientific standards with acceptable restrictions.

Data source

Reference
Reference Type:
publication
Title:
Acute intravenous and intraperitoneal toxicity studies on sodium pentaborate decahydrate and sodium tetraborate decahydrate.
Author:
Easterday OD & Hamel H
Year:
1963
Bibliographic source:
Arch. Int. Pharmacodyn. 143 (1-2)144 – 164.

Materials and methods

Test guideline
Qualifier:
no guideline followed
Principles of method if other than guideline:
The toxicity observations in mice of varying borate-glucose molar ratios and relative potencies was reported following intravenous and intraperitoneal administration. Also presented were data showing the effect of age on tetraborate toxicity. Swiss mice were administered with reagent grade sodium tetraborate decahydrate and intravenous 50 % d-glucose dissolved in sterile water or saline. The doses were injected as mg of the parent drug/g body weight per 0.01 or 0.02 mL. By maintaining a constant borate dose and varying the amount of d-glucose in the injected preparation the effect of different borate-glucose molar ratios on toxicity was determined. The observation period was 24 h after intravenous administration and after intraperitoneal administration 5 to 12 days. The acute toxicity data were statistically analysed by probit transformation, maximum likelihood solution and relative potency techniques.
GLP compliance:
no
Remarks:
Studypre-dates GLP
Limit test:
no

Test material

Constituent 1
Reference substance name:
Sodium pentaborate decahydrate and sodium tetraborate decahydrate
IUPAC Name:
Sodium pentaborate decahydrate and sodium tetraborate decahydrate
Details on test material:
- Name of test material: Sodium pentaborate decahydrate; Sodium tetraborate decahydrate

Test animals

Species:
mouse
Strain:
Swiss
Sex:
male/female

Administration / exposure

Route of administration:
intraperitoneal
Vehicle:
other: Water or saline
Doses:
Sodium pentaborate decahydrate: 2175 and 2300 mg/kg
Sodium tetraborate decahydrate: 2700, 2750, 2800 and 2884 mg/kg
No. of animals per sex per dose:
Sodium pentaborate decahydrate: Between 14 and 42 males; and between 1 and 26 females
Sodium tetraborate decahydrate: Between 7 and 30 males; and between 9 and 34 females
Control animals:
yes

Results and discussion

Effect levelsopen allclose all
Sex:
male/female
Dose descriptor:
LD50
Effect level:
2 737 mg/kg bw
Based on:
other: Borate
Remarks on result:
other: Tetraborate : distilled water; 2737 ± 479
Sex:
male/female
Dose descriptor:
LD50
Effect level:
2 792 mg/kg bw
Based on:
other: Borate
Remarks on result:
other: Tetraborate : saline; 2792 ± 420
Sex:
male/female
Dose descriptor:
LD50
Effect level:
3 037 mg/kg bw
Based on:
other: Borate
Remarks on result:
other: Tetraborate : d-glucose; 3037 ± 620.
Sex:
male/female
Dose descriptor:
LD50
Effect level:
2 817 mg/kg bw
Based on:
other: Borate
Remarks on result:
other: Tetraborate : d-glucose; 2817 ± 243.
Sex:
male/female
Dose descriptor:
LD50
Effect level:
2 375 mg/kg bw
Based on:
other: Borate
Remarks on result:
other: Pentaborate : d-glucose; 2375 ± 118.

Applicant's summary and conclusion

Conclusions:
Toxic responses of intraperitoneally administered sodium pentaborate decahydrate and sodium tetraborate decahydrate were convulsions which generally occurred during the first 3 h. Trunk muscular contractions and opisthotonic responses occassionally occurred. General motor activity and the respiration rate were markedly depressed and usually existed for several hours. Frequently observable motor activity depression continuing through the second day after administration was observed. Most of the deaths occurred during the first 3 days.